[Management of coexistent advanced coronary artery disease and internal carotid artery stenosis]

Anna Kabłak-Ziembicka1, Marta Hlawaty, Jerzy Sadowski

  • 1Klinika Chorób Serca i Naczyń Instytutu Kardiologii Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.

Przeglad Lekarski
|January 9, 2003
PubMed

Insights

A 60-year-old man with unstable angina and carotid artery stenosis underwent a two-stage treatment. Carotid endarterectomy (CEA) was performed first, followed by coronary artery bypass grafting (CABG) a month later, yielding a good outcome.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • The patient presented with symptoms indicative of unstable angina and significant carotid artery stenosis.
  • Diagnostic imaging revealed three-vessel coronary artery disease and high-grade left internal carotid artery stenosis with a thrombosed aneurysm.

Observation:

  • A 60-year-old male patient experienced symptoms of unstable angina and carotid artery stenosis.
  • Coronary angiography identified three-vessel coronary artery disease.
  • Doppler ultrasound and multislice spiral computed tomography confirmed high-grade left internal carotid artery stenosis with a poststenotic aneurysm containing thrombi.

Findings:

  • A high-risk assessment for simultaneous coronary artery bypass grafting (CABG) and carotid endarterectomy (CEA) was determined.
  • A staged surgical approach was chosen, commencing with CEA.
  • The patient subsequently underwent CABG one month after CEA, with successful results.

Implications:

  • This case highlights the successful management of complex cardiovascular and cerebrovascular disease through a staged surgical approach.
  • The findings suggest that a staged CEA followed by CABG can be a safe and effective strategy in high-risk patients.
  • This approach may reduce perioperative risks associated with combined procedures for severe coronary artery disease and carotid stenosis.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...